National Bank Alzheimer

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorCentre Hospitalier Universitaire de Nice

About this trial

The Alzheimer's disease (MY) is a major problem of public health. The French National Database Alzheimer ( BNA) registers(records) all the medical acts made by units of memory(report) and of independent specialists in France.

In 2008, the national Plan Alzheimer 2008 - 2012 had for objective to strengthen the search(research) on the Alzheimer's disease (MY) and for related disorders(confusions), to promote an early diagnosis and to improve at the same time the management of the patients and to support careers(quarries). A specific part(party) of this plan gave rise to the creation of the French national database Alzheimer ( BNA) to supply epidemiological data as well as indicators of activity. Since 2009 The information collected(taken in) in the BNA consists of a set(group) limited by data (CIMA of information minimum Corpus Alzheimer) concerning the demographic, clinical and diagnostic data defined by national consensus. The number of variables is limited to facilitate and to improve the participation in this national database. The participants are the Centers Report (CM)((LECTURE)) and Center Memory(Report) of Resources and Search(Research) (CMRR) and independent specialists. In 2015 more than 500 Centers send CIMA to the BNA.

The plan Disease Neurodegenerative 2014 - 2019 wishes to pursue and to amplify the BNA.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients consulting in French Memory Centres

Disqualifiers

None

Trial population

Alzheimer desease and related disorders patients

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • non ontervention / observational study

    Other intervention

    non intervention

Treatment groups

Not listed Participants
are divided into 1 treatment group
Group A: Alzheimer desease and related disorders1 intervention

Trial outcomes

Primary outcomes

1

Evolution of the morbi-mortality

number of people suffering from a disease

Time frame
16 years
2

Evolution of the morbi-mortality

number of deaths

Time frame
16 years

Secondary outcomes

1

number of the miscellaneous determiners of Access to healthcare or diagnosis

number of the determiners of the access to healthcare and diagnosis

Time frame
16 years

Other outcomes

1

New therapeutic plans

Participate in the evaluation of new therapeutic plans of care

Time frame
16 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.